Submitted by Anonymous (not verified) on 9 December 2025 - 14:33
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised